PRIA Logo™
115-hr-3536115th Congress

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Sponsored By: Representative DeFazio, Peter A. [D-OR-4]

Unknown

Summary

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

DeFazio, Peter A. [D-OR-4]

OR • D

Cosponsors

  • JOHN CONYERS

    MI • D

    Sponsored 9/5/2017

  • Rep. Schakowsky, Janice D. [D-IL-9]

    IL • D

    Sponsored 9/5/2017

  • Rep. Kaptur, Marcy [D-OH-9]

    OH • D

    Sponsored 9/5/2017

  • ELIJAH CUMMINGS

    MD • D

    Sponsored 9/5/2017

  • Rep. Grijalva, Raúl M. [D-AZ-7]

    AZ • D

    Sponsored 9/7/2017

  • LOUISE SLAUGHTER

    NY • D

    Sponsored 11/8/2017

  • Rep. Khanna, Ro [D-CA-17]

    CA • D

    Sponsored 7/11/2018

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation